GAITHERSBURG, Md. — The maker of the onlystill widely available in the United States is raising doubts about its ability to stay in business.
"Given these uncertainties, substantial doubt exists regarding our ability to continue as a going concern," the company report said, according to CNN. The U.S. Food and Drug Administration is looking at requiring an annual reformulation for the coronavirus vaccine, in time for most Americans to be"We don't know what the strain selection is yet from FDA. We don't know what global health authorities may want from a regulatory standpoint on how the new vaccine needs to look," Jacobs told Reuters.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: